Search Results for: Lupus RD Landscape Set to
Articles
February 13, 2017
Lupus R&D Landscape Set to be Dominated by Big Pharma & Small Biotech Partnerships February 13, 2017
The lupus market, which is set to reach $3.2 billion by 2025 and has historically been dominated by inexpensive generic...
April 4, 2022
EXECUTIVE INTERVIEW - inVibe: Changing the Research Game With Voice April 4, 2022
Fabio Gratton, CEO of inVibe, discusses patient-focused drug development (PFDD), his company’s language model, and the value this technology brings to a patient’s treatment journey.
